SEO URLwww.firestrike.ai/deals/ventyx-biosciences-lilly-acquisition-2026-5
acquisitionAnnounced · Jan 8, 2026biopharmaceuticalSource · CredibleArticle · Factual
Lilly acquires Ventyx Biosciences
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$1.2B
Target
Ventyx Biosciences
NASDAQ: VTYX · San Diego, California
Acquirer
Lilly
Full Acquisition
Status
Announced
Lilly agreed to acquire Ventyx Biosciences. Reported deal value: $1.2B. Status: Announced. Sector: biopharmaceutical. Target headquarters context: San Diego, California, United States.
This page summarizes publicly available information about the transaction as of 2026-01-08. Figures and status may change as filings and press coverage update.
Lilly acquires inflammatory firm Ventyx Biosciences for $1. 2bn deal
Deal timeline
Announced
Jan 8, 2026 · europeanpharmaceuticalreview.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biopharmaceutical with a reported deal value of $1.2B. Figures and status may change as sources update.
Sources: europeanpharmaceuticalreview.com · Primary article · FireStrike proprietary index